QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 30 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $69,000 | -53.1% | 258,419 | 0.0% | 0.00% | – |
| Q2 2022 | $147,000 | -33.5% | 258,419 | -22.8% | 0.00% | – |
| Q1 2022 | $221,000 | -36.3% | 334,675 | +3.0% | 0.00% | – |
| Q4 2021 | $347,000 | -19.7% | 325,043 | -2.0% | 0.00% | – |
| Q3 2021 | $432,000 | -34.9% | 331,773 | -0.5% | 0.00% | – |
| Q2 2021 | $664,000 | -22.7% | 333,405 | +4.9% | 0.00% | – |
| Q1 2021 | $859,000 | -10.2% | 317,818 | 0.0% | 0.00% | – |
| Q4 2020 | $957,000 | -38.5% | 317,818 | +1.2% | 0.00% | – |
| Q3 2020 | $1,555,000 | +77650.0% | 314,126 | +54247.1% | 0.00% | – |
| Q2 2020 | $2,000 | – | 578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|